Patents for A61P 33 - Antiparasitic agents (21,787)
10/2002
10/09/2002EP1246624A2 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans
10/09/2002CN1373771A Vaccine
10/09/2002CN1373115A Synthesizing process for phenylhydroxy acetic acid and its salts, and application thereof in treating malaria
10/09/2002CN1092059C Medicine for treating toxoplasmosis
10/09/2002CN1092048C Compound piperaquine tablet
10/09/2002CN1092030C Method for extracting sulfur-contg. component part from galic and method for preparation of oil and fat contg. same
10/08/2002US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
10/08/2002US6461607 Probiotic, lactic acid-producing bacteria and uses thereof
10/08/2002CA2252982C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
10/03/2002WO2002077074A1 Compounds for a controlled release of active compounds
10/03/2002WO2002077008A1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same
10/03/2002WO2002077005A1 Pesticidal spinosyn derivatives
10/03/2002WO2002077004A1 Synthetic derivatives of 21-butenyl and related spinosyns
10/03/2002WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076500A1 Vaccine for the treatment of tubercolosis and other intracellular infections diseases
10/03/2002WO2002076485A2 Vaccine for modulating between t1 and t2 immune responses
10/03/2002WO2002076451A1 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases
10/03/2002WO2002057248A3 Inhibitors of cruzipain and other cysteine proteases
10/03/2002WO2001071004A3 Proteases
10/03/2002US20020143055 Administering an effective amount of propionoyloxymethyl propionate, butyroyloxymethyl butyrate, or mixtures for therapy of illness
10/03/2002US20020143043 For therapy and prophylaxis of rheumatoid arthritis, or of allergic disorders, asthma, inflammation; inhibitors of the adhesion and migration of leucocytes and/or antagonists of adhesion receptor VLA-4 belonging to the integrins group
10/03/2002US20020143018 For therapy of animals infected with parasites that cause abortigenic or neurologic diseases, for therapy of parasitic protozoa such as coccidia that cause abortigenic or neurologic diseases of mammals
10/03/2002US20020142972 Antiparasitic formulation
10/03/2002US20020142969 Using didepsipeptide for the control of endoparasites in medicine and veterinary medicine
10/03/2002US20020142023 Insecticide, miticide
10/03/2002US20020142001 DNA immunization against Chlaymdia infection
10/03/2002US20020141987 Fish serine proteinases and their pharmaceutical and cosmetic use
10/03/2002CA2441809A1 Lipsomal vaccines comprising dilipopetides for modulating t1 and t2 immune responses
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244684A1 Cryptosporidium sporozoite antigens
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244658A2 Azolyl-alkyl azole derivatives, a method for their production and their use as pesticides
10/02/2002EP1244624A1 Anthracene derivatives as anti-cancer agents
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244436A2 Compounds and compositions for use in inhibiting endoparasitic fatty acid biosynthesis
10/02/2002EP1244359A1 Combination of n-phenyl-n'-benzoyl urea derivative and nectin compounds for parasite control
10/02/2002EP0966285B1 Use of (+)mefloquine for the treatment of malaria
10/02/2002EP0896532B1 Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals
10/02/2002EP0817624B1 Inhibitors of metazoan parasite proteases
10/02/2002DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372568A Vaccin
10/02/2002CN1372539A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity
10/02/2002CN1372473A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/02/2002CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease
10/02/2002CN1372462A Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system
10/02/2002CN1371708A Medicine coposition for treating hydatid disease
10/02/2002CN1371689A New pharmaceutical usage of primaquine phosphate
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002US6458363 Method to produce inactivated w/o emulsion adjuvated vaccines
10/01/2002CA2145411C Viscous liquid xylitol compositions and process for preparing the same
10/01/2002CA2065104C Erucyl, brassidyl and nervonyl derivatives
09/2002
09/26/2002WO2002074939A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
09/26/2002WO2002074913A2 Nucleic acid-associated proteins
09/26/2002WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
09/26/2002WO2002074314A1 Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives
09/26/2002WO2002074313A1 Drugs containing reduced vitamin b¿2?
09/26/2002WO2002044126A3 Bisubstituted carbocyclic cyclophilin binding compounds and theirus
09/26/2002WO2002024685A8 Indole derivatives and their use as antifungal and/or antiparasitic agents
09/26/2002WO2002024220A3 Vaccine comprising heat stress proteins from herbaceous plants
09/26/2002WO2001090159B1 Compositions and methods for delivery of a molecule into a cell
09/26/2002WO2001083775A3 Proteases
09/26/2002WO2001032156A3 Methods for treating fibroproliferative diseases
09/26/2002US20020137781 Pesticides
09/26/2002US20020137714 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
09/26/2002CA2460779A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
09/26/2002CA2440391A1 Therapeutical method involving subcutaneous administration of drugs containing cephalotaxine derivatives
09/26/2002CA2440272A1 Nucleic acid-associated proteins
09/26/2002CA2439757A1 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
09/25/2002EP1243264A2 Inhibition of nitric oxide production by retinoic acid
09/25/2002EP1243256A1 Vaccines absorbable by the transmucosal way
09/25/2002EP1242579A2 Th1 specific cd4 t cell lines and method for inducing them ex vivo
09/25/2002EP1242438A1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
09/25/2002EP1242415A1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors
09/25/2002EP1242414A1 Pyrazolyl benzyl ethers
09/25/2002EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
09/25/2002EP1242371A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors
09/25/2002EP1242365A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm
09/25/2002EP1242104A2 Process of obtaining thylakoids from plants, pure thylakoids and use thereof
09/25/2002EP1241943A1 Use of polysiloxanes containing quaternary amino groups as formulation auxiliary agents, and agents containing the same
09/25/2002EP0986390B1 Pharmaceutical compositions containing cinchonine dichlorhydrate
09/25/2002EP0938306B1 Antimalarial compositions containing cis-fused cyclopenteno-1,2,4-trioxane derivatives
09/25/2002EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
09/25/2002EP0746312B1 Guanylhydrazones for treating inflammatory conditions
09/25/2002CN1371390A Human G-protein coupled receptor
09/25/2002CN1091369C Ointment for treating face mite disease
09/24/2002WO2001072289A2 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof
09/24/2002US6455508 Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides
09/24/2002US6455504 Pesticidal macrolides
09/24/2002US6455502 Compounds and compositions as protease inhibitors
09/24/2002US6455039 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (mif) gene selected from dirofilaria immitis mif gene and onchocerca volvulus mif gene
09/24/2002CA2404322A1 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof
09/24/2002CA2260914C Parasiticidal pyrazoles
09/20/2002WO2001070692A2 Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides